ZBH vs BIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 08, 2026
ZBH
63.9
AI Score
VS
ZBH Wins
BIO
60.1
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | ZBH | BIO | Winner |
|---|---|---|---|
| Revenue | 2.09B | 592.10M | ZBH |
| Net Income | 238.10M | -527.10M | ZBH |
| Net Margin | 11.4% | -89.0% | ZBH |
| Operating Income | 373.20M | 34.10M | ZBH |
| ROE | 1.9% | -7.7% | ZBH |
| ROA | 1.0% | -5.4% | ZBH |
| Total Assets | 22.72B | 9.79B | ZBH |
| Cash | 424.20M | 507.20M | BIO |
| Debt/Equity | 0.50 | 0.18 | BIO |
| Current Ratio | 1.73 | 3.21 | BIO |
| Free Cash Flow | 323.10M | 78.10M | ZBH |
Frequently Asked Questions
Based on our detailed analysis, ZBH is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.